Scanner combines fluoroscopy, a type of X-ray imaging that allows real-time visualization of body structures, with analytical software to visually document the lung’s air flow as color heat maps.
Preoxygenation is the administration of supplemental oxygen prior to the start of a procedure to increase the content of oxygen in the lung and decrease the risk of hypoxemia
Findings from NIH-supported clinical trial suggest that intravenous acetaminophen has the greatest benefit in the sickest patients.
Six junior faculty and postdoctoral fellows, including four from the Department of Medicine, have been appointed this year to the Vanderbilt Faculty Research Scholars (VFRS) program at Vanderbilt University Medical Center.
E. Wesley Ely, MD, MPH, has received the Paul B. Magnuson Award for Outstanding Achievement in Rehabilitation Research and Development from the U.S. Department of Veterans Affairs (VA).
A new tool to identify infants most at risk for severe respiratory syncytial virus (RSV) illness could aid pediatricians in prioritizing children under 1 to receive a preventive medication before RSV season (October-April).
Julie Bastarache, MD, Assistant Vice President for Clinical & Translational Scientist Development at Vanderbilt University Medical Center, has been elected vice president of the American Society for Clinical Investigation (ASCI) for 2024-2025.
An international research team co-led by Vanderbilt University Medical Center has revealed how variations in gene regulation in different cell types drive pulmonary fibrosis, a progressive respiratory disorder characterized by scarring and loss of functional lung tissue.
Anna Hemnes, MD, professor of Medicine, has been named director of the Division of Allergy, Pulmonary and Critical Care Medicine, physician-in-chief of the Vanderbilt Lung Institute and director of the Center for Lung Research.
Vanderbilt University Medical Center is working with scientists around the U.S. to launch the first phase 3, multicenter, placebo-controlled trial to determine the effect of immunomodulation on Long COVID (LC), also known as long-haul COVID or post-acute sequelae of COVID-19. The study is funded by the National Institutes of Health’s National Institute on Aging.
